Symbol:
Ndufa5
Name:
NADH:ubiquinone oxidoreductase subunit A5
RGD ID:
3155
Description:
Predicted to be involved in respiratory electron transport chain. Part of protein-containing complex. Orthologous to human NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5); PARTICIPATES IN Alzheimer's disease pathway; Huntington's disease pathway; oxidative phosphorylation pathway; INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 3,3',5-triiodo-L-thyronine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
CI-13kD-B; complex I subunit B13; complex I-13kD-B; MGC72911; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5; NADH ubiquinone oxidoreductase subunit B13; NADH-ubiquinone oxidoreductase 13 kDa-B subunit; NADHUO
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 53,962,877 - 53,971,235 (-) NCBI GRCr8 mRatBN7.2 4 52,997,327 - 53,005,685 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 73,659,223 - 73,659,585 (+) Ensembl mRatBN7.2 Ensembl mRatBN7.2 Ensembl 4 52,995,546 - 53,005,598 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 57,984,164 - 57,992,522 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 53,890,983 - 53,899,344 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 52,325,552 - 52,333,908 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 51,590,413 - 51,598,771 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 51,590,413 - 51,598,771 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 51,368,669 - 51,377,027 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 50,649,500 - 50,657,858 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 50,880,073 - 50,888,427 (-) NCBI Celera 4 48,163,115 - 48,171,473 (-) NCBI Celera Cytogenetic Map 4 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ndufa5 Rat (+)-dexrazoxane increases expression ISO Ndufa5 (Mus musculus) 6480464 Dexrazoxane results in increased expression of NDUFA5 mRNA CTD PMID:26873546 Ndufa5 Rat (S)-nicotine increases expression ISO NDUFA5 (Homo sapiens) 6480464 Nicotine results in increased expression of NDUFA5 mRNA CTD PMID:16949557 Ndufa5 Rat 1,2-dichloroethane decreases expression ISO Ndufa5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of NDUFA5 mRNA CTD PMID:28960355 Ndufa5 Rat 1,2-dimethylhydrazine multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFA5 mRNA CTD PMID:22206623 Ndufa5 Rat 1,2-dimethylhydrazine decreases expression ISO Ndufa5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of NDUFA5 mRNA CTD PMID:22206623 Ndufa5 Rat 17alpha-ethynylestradiol affects expression ISO Ndufa5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of NDUFA5 mRNA CTD PMID:17555576 Ndufa5 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NDUFA5 mRNA CTD PMID:15212814 Ndufa5 Rat 17alpha-ethynylestradiol multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFA5 mRNA CTD PMID:17942748 Ndufa5 Rat 17beta-estradiol decreases expression ISO Ndufa5 (Mus musculus) 6480464 Estradiol results in decreased expression of NDUFA5 mRNA CTD PMID:39298647 Ndufa5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFA5 mRNA CTD PMID:17942748 Ndufa5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NDUFA5 mRNA CTD PMID:32109520 and PMID:34747641 Ndufa5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ndufa5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NDUFA5 mRNA CTD PMID:21570461 Ndufa5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ndufa5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NDUFA5 mRNA CTD PMID:20399798 Ndufa5 Rat 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of NDUFA5 mRNA CTD PMID:15953391 Ndufa5 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of NDUFA5 mRNA CTD PMID:24848799 Ndufa5 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Ndufa5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of NDUFA5 mRNA CTD PMID:18648102 Ndufa5 Rat 4,4'-sulfonyldiphenol increases expression ISO Ndufa5 (Mus musculus) 6480464 bisphenol S results in increased expression of NDUFA5 mRNA CTD PMID:39298647 Ndufa5 Rat 4-hydroxyphenyl retinamide affects expression ISO NDUFA5 (Homo sapiens) 6480464 Fenretinide affects the expression of NDUFA5 mRNA CTD PMID:16570282 Ndufa5 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NDUFA5 mRNA CTD PMID:18077114 and PMID:30047161 Ndufa5 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of NDUFA5 mRNA CTD PMID:31881176 Ndufa5 Rat Aflatoxin B2 alpha increases methylation ISO NDUFA5 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of NDUFA5 intron CTD PMID:30157460 Ndufa5 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of NDUFA5 mRNA CTD PMID:30047161 Ndufa5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NDUFA5 mRNA CTD PMID:16483693 Ndufa5 Rat aristolochic acid A decreases expression ISO NDUFA5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of NDUFA5 mRNA CTD PMID:33212167 Ndufa5 Rat aspartame multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Fats more ... CTD PMID:23783067 Ndufa5 Rat astaxanthin multiple interactions ISO Ndufa5 (Mus musculus) 6480464 astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFA5 mRNA] CTD PMID:16964424 Ndufa5 Rat benzene decreases expression EXP 6480464 Benzene results in decreased expression of NDUFA5 mRNA CTD PMID:15878777 Ndufa5 Rat benzo[a]pyrene increases expression ISO Ndufa5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NDUFA5 mRNA CTD PMID:22228805 Ndufa5 Rat biochanin A decreases expression ISO NDUFA5 (Homo sapiens) 6480464 biochanin A results in decreased expression of NDUFA5 mRNA CTD PMID:12111696 Ndufa5 Rat bis(2-ethylhexyl) phthalate increases expression ISO Ndufa5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of NDUFA5 mRNA CTD PMID:33754040 Ndufa5 Rat bisphenol A multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of NDUFA5 protein CTD PMID:26930160 Ndufa5 Rat bisphenol A increases expression ISO NDUFA5 (Homo sapiens) 6480464 bisphenol A results in increased expression of NDUFA5 protein CTD PMID:37567409 Ndufa5 Rat bisphenol A decreases expression ISO Ndufa5 (Mus musculus) 6480464 bisphenol A results in decreased expression of NDUFA5 mRNA CTD PMID:35598803 Ndufa5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NDUFA5 mRNA CTD PMID:32145629 Ndufa5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NDUFA5 mRNA CTD PMID:25181051 Ndufa5 Rat bisphenol AF increases expression ISO NDUFA5 (Homo sapiens) 6480464 bisphenol AF results in increased expression of NDUFA5 protein CTD PMID:34186270 Ndufa5 Rat Bisphenol B increases expression ISO NDUFA5 (Homo sapiens) 6480464 bisphenol B results in increased expression of NDUFA5 protein CTD PMID:34186270 Ndufa5 Rat bisphenol F affects expression ISO Ndufa5 (Mus musculus) 6480464 bisphenol F affects the expression of NDUFA5 mRNA CTD PMID:38685157 Ndufa5 Rat carbon nanotube decreases expression ISO Ndufa5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of NDUFA5 mRNA CTD PMID:25620056 Ndufa5 Rat CGP 52608 multiple interactions ISO NDUFA5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to NDUFA5 gene] CTD PMID:28238834 Ndufa5 Rat chlorohydrocarbon increases expression EXP 6480464 Hydrocarbons and Chlorinated results in increased expression of NDUFA5 mRNA CTD PMID:18077114 Ndufa5 Rat chlorpyrifos decreases expression ISO Ndufa5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of NDUFA5 mRNA CTD PMID:37019170 Ndufa5 Rat clofibrate increases expression ISO Ndufa5 (Mus musculus) 6480464 Clofibrate results in increased expression of NDUFA5 mRNA CTD PMID:17585979 Ndufa5 Rat clofibrate multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA5 mRNA] CTD PMID:17585979 Ndufa5 Rat clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of NDUFA5 mRNA CTD PMID:30047161 Ndufa5 Rat copper(II) sulfate decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of NDUFA5 mRNA CTD PMID:19549813 Ndufa5 Rat corosolic acid decreases expression ISO NDUFA5 (Homo sapiens) 6480464 corosolic acid results in decreased expression of NDUFA5 mRNA CTD PMID:37939859 Ndufa5 Rat cyclosporin A decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NDUFA5 mRNA CTD PMID:20106945 and PMID:25562108 Ndufa5 Rat dexamethasone multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of NDUFA5 mRNA CTD PMID:24848799 Ndufa5 Rat dibutyl phthalate decreases expression ISO Ndufa5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of NDUFA5 mRNA CTD PMID:17361019 and PMID:21266533 Ndufa5 Rat dicrotophos decreases expression ISO NDUFA5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of NDUFA5 mRNA CTD PMID:28302478 Ndufa5 Rat doxorubicin affects expression ISO NDUFA5 (Homo sapiens) 6480464 Doxorubicin affects the expression of NDUFA5 protein CTD PMID:29385562 Ndufa5 Rat doxorubicin decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of NDUFA5 mRNA CTD PMID:29803840 Ndufa5 Rat ethanol affects expression ISO Ndufa5 (Mus musculus) 6480464 Ethanol affects the expression of NDUFA5 mRNA CTD PMID:30319688 Ndufa5 Rat fenthion increases expression ISO Ndufa5 (Mus musculus) 6480464 Fenthion results in increased expression of NDUFA5 mRNA CTD PMID:34813904 Ndufa5 Rat finasteride increases expression EXP 6480464 Finasteride results in increased expression of NDUFA5 mRNA CTD PMID:24136188 Ndufa5 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of NDUFA5 mRNA CTD PMID:24136188 Ndufa5 Rat folic acid multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFA5 mRNA CTD PMID:22206623 Ndufa5 Rat fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of NDUFA5 protein CTD PMID:26930160 Ndufa5 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NDUFA5 mRNA CTD PMID:22061828 Ndufa5 Rat glyphosate decreases expression ISO Ndufa5 (Mus musculus) 6480464 Glyphosate results in decreased expression of NDUFA5 mRNA CTD PMID:36608876 Ndufa5 Rat glyphosate increases expression ISO Ndufa5 (Mus musculus) 6480464 Glyphosate results in increased expression of NDUFA5 protein CTD PMID:37208198 Ndufa5 Rat hydralazine multiple interactions ISO NDUFA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA5 mRNA CTD PMID:17183730 Ndufa5 Rat isoniazide affects expression ISO Ndufa5 (Mus musculus) 6480464 Isoniazid affects the expression of NDUFA5 mRNA CTD PMID:24848797 Ndufa5 Rat ivermectin decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of NDUFA5 protein CTD PMID:32959892 Ndufa5 Rat ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of NDUFA5 mRNA CTD PMID:37077353 Ndufa5 Rat lipopolysaccharide multiple interactions ISO NDUFA5 (Homo sapiens) 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA5 mRNA CTD PMID:31059760 Ndufa5 Rat Mesaconitine increases expression EXP 6480464 mesaconitine results in increased expression of NDUFA5 protein CTD PMID:37182599 Ndufa5 Rat methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of NDUFA5 mRNA CTD PMID:19149911 Ndufa5 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NDUFA5 mRNA CTD PMID:30467583 Ndufa5 Rat methidathion increases expression ISO Ndufa5 (Mus musculus) 6480464 methidathion results in increased expression of NDUFA5 mRNA CTD PMID:34813904 Ndufa5 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of NDUFA5 mRNA CTD PMID:30047161 Ndufa5 Rat monosodium L-glutamate decreases expression ISO Ndufa5 (Mus musculus) 6480464 Sodium Glutamate results in decreased expression of NDUFA5 mRNA CTD PMID:20111022 Ndufa5 Rat monosodium L-glutamate multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Fats more ... CTD PMID:20111022 and PMID:23783067 Ndufa5 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of NDUFA5 mRNA CTD PMID:24136188 Ndufa5 Rat nicotine increases expression ISO NDUFA5 (Homo sapiens) 6480464 Nicotine results in increased expression of NDUFA5 mRNA CTD PMID:16949557 Ndufa5 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of NDUFA5 mRNA CTD PMID:24136188 Ndufa5 Rat nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of NDUFA5 mRNA CTD PMID:12102619 Ndufa5 Rat paracetamol multiple interactions ISO Ndufa5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA5 mRNA] CTD PMID:17585979 Ndufa5 Rat paracetamol multiple interactions ISO NDUFA5 (Homo sapiens) 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA5 mRNA CTD PMID:31059760 Ndufa5 Rat paracetamol decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of NDUFA5 mRNA CTD PMID:22230336 more ... Ndufa5 Rat paracetamol affects expression ISO Ndufa5 (Mus musculus) 6480464 Acetaminophen affects the expression of NDUFA5 mRNA CTD PMID:17562736 Ndufa5 Rat paraquat decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Paraquat results in decreased expression of NDUFA5 protein CTD PMID:34064677 Ndufa5 Rat perfluorooctane-1-sulfonic acid decreases expression ISO Ndufa5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of NDUFA5 mRNA CTD PMID:20936131 Ndufa5 Rat perfluorooctane-1-sulfonic acid increases expression ISO NDUFA5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of NDUFA5 mRNA CTD PMID:25812627 Ndufa5 Rat perfluorooctane-1-sulfonic acid decreases expression ISO NDUFA5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of NDUFA5 mRNA CTD PMID:27153767 Ndufa5 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ndufa5 (Mus musculus) 6480464 PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of NDUFA5 mRNA] CTD PMID:20936131 Ndufa5 Rat perfluorooctanoic acid decreases expression ISO Ndufa5 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of NDUFA5 mRNA CTD PMID:20936131 Ndufa5 Rat perfluorooctanoic acid increases expression ISO NDUFA5 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of NDUFA5 mRNA CTD PMID:25812627 Ndufa5 Rat pirinixic acid increases expression ISO Ndufa5 (Mus musculus) 6480464 pirinixic acid results in increased expression of NDUFA5 mRNA CTD PMID:18301758 Ndufa5 Rat piroxicam decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Piroxicam results in decreased expression of NDUFA5 mRNA CTD PMID:21858171 Ndufa5 Rat resveratrol increases expression ISO Ndufa5 (Mus musculus) 6480464 resveratrol results in increased expression of NDUFA5 mRNA CTD PMID:22610192 Ndufa5 Rat rotenone decreases expression ISO Ndufa5 (Mus musculus) 6480464 Rotenone results in decreased expression of NDUFA5 mRNA CTD PMID:23186747 Ndufa5 Rat sodium arsenate decreases expression ISO Ndufa5 (Mus musculus) 6480464 sodium arsenate results in decreased expression of NDUFA5 mRNA CTD PMID:30953684 Ndufa5 Rat sodium arsenite increases expression ISO Ndufa5 (Mus musculus) 6480464 sodium arsenite results in increased expression of NDUFA5 mRNA CTD PMID:30130555 Ndufa5 Rat sodium arsenite decreases expression ISO NDUFA5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of NDUFA5 mRNA CTD PMID:38568856 Ndufa5 Rat Soman increases expression EXP 6480464 Soman results in increased expression of NDUFA5 mRNA CTD PMID:19281266 Ndufa5 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of NDUFA5 mRNA CTD PMID:30047161 Ndufa5 Rat sulforaphane increases expression ISO Ndufa5 (Mus musculus) 6480464 sulforaphane results in increased expression of NDUFA5 mRNA CTD PMID:30529165 Ndufa5 Rat sulindac increases expression EXP 6480464 Sulindac results in increased expression of NDUFA5 mRNA CTD PMID:24136188 Ndufa5 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NDUFA5 mRNA CTD PMID:33387578 Ndufa5 Rat thimerosal increases expression ISO NDUFA5 (Homo sapiens) 6480464 Thimerosal results in increased expression of NDUFA5 mRNA CTD PMID:27188386 Ndufa5 Rat thiram decreases expression ISO NDUFA5 (Homo sapiens) 6480464 Thiram results in decreased expression of NDUFA5 mRNA CTD PMID:38568856 Ndufa5 Rat titanium dioxide decreases methylation ISO Ndufa5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NDUFA5 gene CTD PMID:35295148 Ndufa5 Rat toluene affects expression EXP 6480464 Toluene affects the expression of NDUFA5 mRNA CTD PMID:21827849 Ndufa5 Rat tributylstannane increases expression ISO Ndufa5 (Mus musculus) 6480464 tributyltin results in increased expression of NDUFA5 mRNA CTD PMID:24848799 Ndufa5 Rat triphenyl phosphate affects expression ISO NDUFA5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of NDUFA5 mRNA CTD PMID:37042841 Ndufa5 Rat tunicamycin decreases expression ISO Ndufa5 (Mus musculus) 6480464 Tunicamycin results in decreased expression of NDUFA5 mRNA CTD PMID:17127020 Ndufa5 Rat valproic acid multiple interactions ISO NDUFA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA5 mRNA CTD PMID:17183730 Ndufa5 Rat valproic acid increases expression ISO NDUFA5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NDUFA5 mRNA CTD PMID:29154799
Imported Annotations - KEGG (archival)
(+)-dexrazoxane (ISO) (S)-nicotine (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3,3',5-triiodo-L-thyronine (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) Aflatoxin B2 alpha (ISO) amitrole (EXP) ammonium chloride (EXP) aristolochic acid A (ISO) aspartame (ISO) astaxanthin (ISO) benzene (EXP) benzo[a]pyrene (ISO) biochanin A (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Bisphenol B (ISO) bisphenol F (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chlorohydrocarbon (EXP) chlorpyrifos (ISO) clofibrate (ISO) clotrimazole (EXP) copper(II) sulfate (ISO) corosolic acid (ISO) cyclosporin A (ISO) dexamethasone (ISO) dibutyl phthalate (ISO) dicrotophos (ISO) doxorubicin (ISO) ethanol (ISO) fenthion (ISO) finasteride (EXP) flutamide (EXP) folic acid (ISO) fructose (EXP) gentamycin (EXP) glyphosate (ISO) hydralazine (ISO) isoniazide (ISO) ivermectin (ISO) ketoconazole (EXP) lipopolysaccharide (ISO) Mesaconitine (EXP) methamphetamine (EXP) methapyrilene (EXP) methidathion (ISO) methimazole (EXP) monosodium L-glutamate (ISO) nefazodone (EXP) nicotine (ISO) nimesulide (EXP) nitroglycerin (EXP) paracetamol (ISO) paraquat (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) pirinixic acid (ISO) piroxicam (ISO) resveratrol (ISO) rotenone (ISO) sodium arsenate (ISO) sodium arsenite (ISO) Soman (EXP) sulfadimethoxine (EXP) sulforaphane (ISO) sulindac (EXP) tetrachloromethane (EXP) thimerosal (ISO) thiram (ISO) titanium dioxide (ISO) toluene (EXP) tributylstannane (ISO) triphenyl phosphate (ISO) tunicamycin (ISO) valproic acid (ISO)
1.
The polypeptide composition of the mitochondrial NADH: ubiquinone reductase complex from several mammalian species.
Cleeter MW and Ragan CI, Biochem J. 1985 Sep 15;230(3):739-46.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model.
George AJ, etal., Neurotox Res. 2010 May;17(4):360-79. doi: 10.1007/s12640-009-9112-3. Epub 2009 Sep 16.
4.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
5.
KEGG: Kyoto Encyclopedia of Genes and Genomes
KEGG
6.
Molecular cloning of the rat NADH:ubiquinone oxidoreductase subunit and its up-regulation in the facial muscle after denervation: detected by means of differential display.
Kitahara T, etal., Neurol Res. 1996 Aug;18(4):329-36.
7.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
8.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
9.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
10.
GOA pipeline
RGD automated data pipeline
11.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
12.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
13.
Comprehensive gene review and curation
RGD comprehensive gene curation
14.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
Ndufa5 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 53,962,877 - 53,971,235 (-) NCBI GRCr8 mRatBN7.2 4 52,997,327 - 53,005,685 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 73,659,223 - 73,659,585 (+) Ensembl mRatBN7.2 Ensembl mRatBN7.2 Ensembl 4 52,995,546 - 53,005,598 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 57,984,164 - 57,992,522 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 53,890,983 - 53,899,344 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 52,325,552 - 52,333,908 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 51,590,413 - 51,598,771 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 51,590,413 - 51,598,771 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 51,368,669 - 51,377,027 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 50,649,500 - 50,657,858 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 50,880,073 - 50,888,427 (-) NCBI Celera 4 48,163,115 - 48,171,473 (-) NCBI Celera Cytogenetic Map 4 q22 NCBI
NDUFA5 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 123,536,997 - 123,601,651 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 123,536,997 - 123,557,904 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 123,177,051 - 123,241,705 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 122,968,319 - 122,985,194 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 7 122,775,033 - 122,791,909 NCBI Celera 7 117,984,821 - 118,001,712 (-) NCBI Celera Cytogenetic Map 7 q31.32 NCBI HuRef 7 117,543,876 - 117,560,767 (-) NCBI HuRef CHM1_1 7 123,114,373 - 123,131,247 (-) NCBI CHM1_1 T2T-CHM13v2.0 7 124,853,763 - 124,918,422 (-) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 122,569,696 - 122,586,588 (-) NCBI
Ndufa5 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 24,518,661 - 24,527,689 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 6 24,518,665 - 24,528,012 (-) Ensembl GRCm39 Ensembl GRCm38 6 24,518,662 - 24,527,690 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 24,518,666 - 24,528,013 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 24,468,666 - 24,477,687 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 6 24,468,676 - 24,477,697 (-) NCBI MGSCv36 mm8 Celera 6 24,530,384 - 24,539,405 (-) NCBI Celera Cytogenetic Map 6 A3.1 NCBI cM Map 6 11.28 NCBI
Ndufa5 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955479 5,064,652 - 5,080,215 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955479 5,065,948 - 5,080,215 (-) NCBI ChiLan1.0 ChiLan1.0
NDUFA5 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 160,409,229 - 160,426,155 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 12,419,478 - 12,436,355 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 7 115,547,062 - 115,563,948 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 7 128,230,035 - 128,246,800 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 7 128,230,035 - 128,246,800 (-) Ensembl panpan1.1 panPan2
NDUFA5 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 14 11,995,862 - 12,008,257 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 14 11,680,175 - 11,692,562 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 14 11,773,697 - 11,786,109 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 14 11,773,694 - 11,787,826 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 14 11,963,395 - 11,975,792 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 14 11,701,242 - 11,713,645 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 14 11,941,763 - 11,954,191 (+) NCBI UU_Cfam_GSD_1.0
Ndufa5 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 50,275,192 - 50,288,699 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936605 1,915,031 - 1,928,732 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936605 1,915,246 - 1,928,853 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NDUFA5 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 18 23,881,966 - 23,900,855 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 18 23,881,872 - 23,896,699 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 18 25,478,874 - 25,492,248 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NDUFA5 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 21 92,330,693 - 92,348,567 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 21 92,327,822 - 92,348,591 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666042 11,117,409 - 11,135,413 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ndufa5
.
Predicted Target Of
Count of predictions: 51 Count of miRNA genes: 47 Interacting mature miRNAs: 50 Transcripts: ENSRNOT00000008325 Prediction methods: Microtar, Rnahybrid Result types: miRGate_prediction
2302371 Stl22 Serum triglyceride level QTL 22 5.15 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 57114705 Rat 2303585 Bw86 Body weight QTL 86 4 body mass (VT:0001259) body weight (CMO:0000012) 4 14678065 59678065 Rat 1358352 Srcrt3 Stress Responsive Cort QTL 3 2.29 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 38465774 146803430 Rat 61445 Strs3 Sensitivity to stroke QTL 3 3 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 4 40433388 85433388 Rat 6893678 Bw108 Body weight QTL 108 2.6 0.006 body mass (VT:0001259) body weight (CMO:0000012) 4 43457976 88457976 Rat 8552906 Pigfal3 Plasma insulin-like growth factor 1 level QTL 3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 4 10084089 55084089 Rat 10755501 Bp390 Blood pressure QTL 390 2.5 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 4 26775591 168368347 Rat 1331807 Rf31 Renal function QTL 31 2.988 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 4 39524264 74726312 Rat 6478766 Anxrr47 Anxiety related response QTL 47 0.09637 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 4 10084089 55084089 Rat 8552782 Vie1 Viral induced encephalitis QTL 1 26.4 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 631642 Stl2 Serum triglyceride level QTL 2 3.3 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5219178 56647776 Rat 6478769 Anxrr48 Anxiety related response QTL 48 0.02514 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 10084089 55084089 Rat 631261 Tcas3 Tongue tumor susceptibility QTL 3 6.88 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 4 10814170 91360527 Rat 2312567 Glom19 Glomerulus QTL 19 1.9 0.006 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 4 45456990 146803430 Rat 10450825 Scl78 Serum cholesterol level QTL 78 3.7 0.01 blood VLDL cholesterol amount (VT:0005144) blood low density lipoprotein cholesterol level (CMO:0000053) 4 49178116 57114705 Rat 2313401 Anxrr27 Anxiety related response QTL 27 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 4 17933508 62933508 Rat 10450821 Scl77 Serum cholesterol level QTL 77 4.1 0.01 blood VLDL cholesterol amount (VT:0005144) blood high density lipoprotein cholesterol level (CMO:0000052) 4 49178116 57114705 Rat 8655961 Kidm43 Kidney mass QTL 43 18 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 4 36303261 103194984 Rat 10450818 Scl76 Serum cholesterol level QTL 76 3.6 0.01 blood VLDL cholesterol amount (VT:0005144) blood high density lipoprotein cholesterol level (CMO:0000052) 4 49178116 57114705 Rat 1354612 Foco1 Food consumption QTL 1 8.87 eating behavior trait (VT:0001431) food intake rate (CMO:0000427) 4 44463908 148090542 Rat 6909128 Pancm4 Pancreatic morphology QTL 4 11.35 pancreas mass (VT:0010144) pancreas wet weight (CMO:0000626) 4 26907285 75585128 Rat 8694374 Bw155 Body weight QTL 155 3.39 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 4 10084089 55084089 Rat 2303168 Bp330 Blood pressure QTL 330 4.25 0.017 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 4 5214602 146446691 Rat 8552801 Bw143 Body weight QTL 143 7.3 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 4 34430484 82490359 Rat 61475 Aia2 Adjuvant induced arthritis QTL 2 5.8 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 4 39505275 73892441 Rat 8694439 Bw168 Body weight QTL 168 9.57 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 4 40433414 85433414 Rat 61412 Pia2 Pristane induced arthritis QTL 2 3.9 joint integrity trait (VT:0010548) post-insult time to onset of experimental arthritis (CMO:0001450) 4 21333343 62278020 Rat 6478724 Anxrr35 Anxiety related response QTL 35 0.00449 defecation behavior trait (VT:0010462) defecation measurement (CMO:0000997) 4 10084089 55084089 Rat 8655906 Rf60 Renal function QTL 60 3.8 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 4 29494195 81006281 Rat 619616 Bp79 Blood pressure QTL 79 0.0292 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 4 5214602 78882945 Rat 1576305 Emca6 Estrogen-induced mammary cancer QTL 6 5.8 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 4 44463720 155883716 Rat 7387227 Uae40 Urinary albumin excretion QTL 40 2.9 0.0052 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 4 17946999 62946999 Rat 6909122 Insul22 Insulin level QTL 22 4.63 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 4 26907285 75585128 Rat 8552809 Vie5 Viral induced encephalitis QTL 5 25.3 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 1358203 Stl19 Serum triglyceride level QTL 19 2.8 0.002 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 65958103 Rat 1354660 Salc1 Saline consumption QTL 1 11.26 drinking behavior trait (VT:0001422) saline drink intake rate (CMO:0001627) 4 44463908 148090542 Rat 1298082 Stresp4 Stress response QTL 4 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 50119848 146803430 Rat 9590304 Scort17 Serum corticosterone level QTL 17 4.96 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 10084089 55084089 Rat 1300139 Hrtrt6 Heart rate QTL 6 2.85 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 4 39524264 116179656 Rat 12798520 Anxrr55 Anxiety related response QTL 55 4.45 0.01 locomotor behavior trait (VT:0001392) number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) 4 32583980 114627242 Rat 2316958 Gluco58 Glucose level QTL 58 10 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 4 11320076 180699135 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000008325 ⟹ ENSRNOP00000008325
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 4 51,590,413 - 51,598,771 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000020076 ⟹ ENSRNOP00000092529
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 73,659,223 - 73,659,585 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000096026 ⟹ ENSRNOP00000078262
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 52,995,546 - 53,005,598 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000100355 ⟹ ENSRNOP00000089514
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 52,995,546 - 53,005,598 (-) Ensembl
RefSeq Acc Id:
NM_012985 ⟹ NP_037117
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 53,962,877 - 53,971,235 (-) NCBI mRatBN7.2 4 52,997,327 - 53,005,685 (-) NCBI Rnor_6.0 4 51,590,413 - 51,598,771 (-) NCBI Rnor_5.0 4 51,368,669 - 51,377,027 (-) NCBI RGSC_v3.4 4 50,649,500 - 50,657,858 (-) RGD Celera 4 48,163,115 - 48,171,473 (-) RGD
Sequence:
TGAATTCGTGGGTTACCCCTAGCCCCGCCTGAGAGGTGGGAGCCAAGTGCTTTCTTGGGTGACACAGGAGCAGCTTCTACGTTCGATTGAGCGGGCCTGGGAAAGGTTCCCAGAAGGCCGCGCGCTGG
hide sequence
RefSeq Acc Id:
NP_037117 ⟸ NM_012985
- UniProtKB:
Q63362 (UniProtKB/Swiss-Prot), A6IE84 (UniProtKB/TrEMBL), A0A8I6AIC3 (UniProtKB/TrEMBL)
- Sequence:
MAGLVKKTTGLVGLAVCDTPHERLTILYTKILDLLKHFPKHAAYRKYTEQITSEKLELVKLEPDVKKLENLLQGGEVEEVILQAEKELSLARKMLQWKPWEPLVEEPPANQWKWPI
hide sequence
Ensembl Acc Id:
ENSRNOP00000008325 ⟸ ENSRNOT00000008325
Ensembl Acc Id:
ENSRNOP00000089514 ⟸ ENSRNOT00000100355
Ensembl Acc Id:
ENSRNOP00000078262 ⟸ ENSRNOT00000096026
Ensembl Acc Id:
ENSRNOP00000092529 ⟸ ENSRNOT00000020076
RGD ID: 13692904 Promoter ID: EPDNEW_R3429 Type: initiation region Name: Ndufa5_1 Description: NADH:ubiquinone oxidoreductase subunit A5 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 4 51,598,638 - 51,598,698 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-11-30
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
Ndufa5
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2002-11-06
Ndufa5
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5
NADH ubiquinone oxidoreductase subunit B13
Name updated
625702 APPROVED
2002-06-10
Ndufa5
NADH ubiquinone oxidoreductase subunit B13
Symbol and Name status set to approved
70586 APPROVED
